Antonios Danikas, based in Canton of Zug, Switzerland, is currently a Business Development Director at Fresenius Kabi, bringing experience from previous roles at Helm Ag, Experientia, Fenix Group International, LLC and Teva Pharmaceuticals. Antonios Danikas holds a 1999 - 2003 PhD in Biochemistry @ King's College London. With a robust skill set that includes Oncology, Pharmaceutical Industry, Biotechnology, Drug Development, Lifesciences and more, Antonios Danikas contributes valuable insights to the industry. Antonios Danikas has 5 emails and 1 mobile phone number on RocketReach.